SEARCH WITHIN CONTENT
Citation Information : Journal of Ultrasonography. Volume 15, Issue 63, Pages 410-422, DOI: https://doi.org/10.15557/JoU.2015.0038
License : (CC BY-NC-ND 4.0)
Received Date : 06-September-2015 / Accepted: 17-October-2015 / Published Online: 13-September-2016
Polycystic ovary syndrome is a multi-factorial disease. Its etiopathogenesis has not been elucidated in detail. It is the most common endocrine disorder in women of child-bearing age. This disease entity is primarily characterized by disrupted ovulation and hyperandrogenism, but the clinical picture can be diversifi ed and symptom intensity can vary. Currently, the sonographic assessment of ovaries is one of the obligatory criteria for the diagnosis of PCOS according to the Rotterdam consensus (2003) and Androgen Excess & PCOS Society (2006). This criterion is determined by the presence of ≥12 follicles within the ovary with a diameter of 2–9 mm and/or ovarian volume ≥10 cm3. Such an ultrasound image in one gonad only is suffi cient to defi ne polycystic ovaries. The coexistence of polycystic ovaries with polycystic ovary syndrome is confi rmed in over 90% of cases irrespective of ethnic factors or race. However, because of the commonness of ultrasound features of polycystic ovaries in healthy women, the inclusion of this sign to the diagnostic criteria of polycystic ovary syndrome is still questioned. The development
of new technologies has an undoubted infl uence on the percentage of diagnosed polycystic ovaries. This process has caused an increase in the percentage of polycystic ovary diagnoses since the Rotterdam criteria were published. It is therefore needed to prepare new commonly accepted diagnostic norms concerning the number of ovarian follicles and the standardization of the technique in which they are counted. The assessment of anti-Müllerian hormone levels as an equivalent of ultrasound features of polycystic ovaries is a promising method. However, analytic methods have to be standardized in order to establish commonly accepted diagnostic norms.
1. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–191.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO:The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745–2749.
3. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar- Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434–2438.
4. Abbott DH, Tarantal AF, Dumesic DA: Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009; 71: 776–784.
5. Oberfi eld SE, Sopher AB, Gerken AT: Approach to the girl with early onset of pubic hair. J Clin Endocrinol Metab 2011; 96: 1610–1622.
6. Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J: Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet 2013; 287: 525–531.
7. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ:The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544–551.
8. Szydlarska D, Grzesiuk W, Bar-Andziak E: Kontrowersje wokół patogenezy zespołu policystycznych jajników. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii 2010; 6: 141–146.
9. Bachanek M, Sawicki W: Zespół metaboliczny a zespół policystycznych jajników. In: Mamcarz A: Zespół metaboliczny. Medical Education, Warszawa 2008: 567–577.
10. Zawadski JK, Dunaif A: Polycystic ovary syndrome. Blackwell Scientifi c, Boston 1992.
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks
related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25.
12. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.
13. Pache TD, Wladimiroff JW, Hop WC, Fauser BC: How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 1992; 183: 421–423.
14. van Santbrink EJ, Hop WC, Fauser BC: Classifi cation of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997; 67: 452–458.
15. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D: Ultrasound examination of polycystic ovaries: is it worth counting the
follicles? Hum Reprod 2003; 18: 598–603.
16. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al.; Androgen Excess Society: Positions statement: criteria for defi ning polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91: 4237–4245.
17. Adams J, Polson DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293: 355–359.
18. Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F: The antral follicle count: practical recommendations for better standardization. Fertil Steril 2010; 94: 1044–1051.
19. Lujan ME, Brooks ED, Kepley AL, Chizen DR, Pierson RA, Peppin AK:Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome. Ultrasound Med Biol 2010; 36: 712–718.
20. Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ: Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol 2010; 35: 354–360.
21. Jayaprakasan K, Walker KF, Clewes JS, Johnson IR, Raine-Fenning NJ: The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques. Ultrasound Obstet Gynecol 2007; 29: 335–341.
22. Scheffer GJ, Broekmans FJM, Bancsi LF, Habbema JD, Te Velde ER:Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 2002; 20: 270–275. 23. Battaglia C, Battaglia B, Morotti E, Paradisi R, Zanetti I, Meriggiola MC, Venturoli S: Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal/ovarian volume ratio as a new diagnostic criterion. J Ultrasound Med 2012; 31: 1015–1024.
24. Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ et al.: Defi nition and signifi cance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2014; 20: 334–352.
25. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al.: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456–488.
26. Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P et al.: Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the defi nition of polycystic ovaries. Hum Reprod 2011;26: 3123–3129.
27. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N et al.:Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013; 28: 1361–1368.
28. Balen AH, Laven JS, Tan SL, Dewailly D: Ultrasound assessment of the polycystic ovary: international consensus defi nitions. Hum Reprod Update 2003; 9: 505–514.
29. Chen Y, Li L, Chen X, Zhang Q, Wang W, Li Y et al.: Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women. Ultrasound Obstet Gynecol 2008; 32: 700–703.
30. Köşüş N, Köşüş A, Turhan NÖ, Kamalak Z: Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries? Eur J Obstet Gynecol Reprod Biol 2011; 154: 177–181.
31. Deb S, Campbell BK, Clewes JS, Pincott-Allen C, Raine-Fenning NJ:Intracycle variation in number of antral follicles stratifi ed by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles. Ultrasound Obstet Gynecol 2013;41: 216–222.
32. Bentzen JG, Forman JL, Johannsen TH, Pinborg A, Larsen EC, Andersen AN: Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab 2013; 98:1602–1611.
33. Lujan ME, Chizen DR, Peppin AK, Dhir A, Pierson RA: Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement. J Ovarian Res 2009; 2: 6.
34. Carmina E, Orio F, Palomba S, Longo RA, Lombardi G, Lobo RA: Ovarian size and blood fl ow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril 2005; 84:413–419.
35. Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ et al.: Ovarian volume related to age. Gynecol Oncol 2000; 77: 410–412.36. Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R et al.: Ultrasound in polycystic ovary syndrome – the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod 2007; 22: 2501–2508.
37. Pascual MA, Graupera B, Hereter L, Tresserra F, Rodriguez I, Alcázar JL: Assessment of ovarian vascularization in the polycystic ovary by three-dimensional power Doppler ultrasonography. Gynecol Endocrinol 2008; 24: 631–636.
38. Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM: Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013; 98: 3332–3340.
39. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D: Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88: 5957–5962.
40. Laven JS, Mulders AG, Visser JA,Themmen AP, DeJong FH, Fauser BC:Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004; 89: 318–323.
41. Govind A, Obhrai MS, Clayton RN: Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999; 84: 38–43.
42. Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E et al.: Reconciling the defi nitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab 2010; 95: 4399–4405.
43. Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R et al.: The polycystic ovary post-Rotterdam: a common, age-dependent fi nding in ovulatory women without metabolic signifi cance. J Clin Endocrinol Metab 2010; 95: 4965-4972.
44. Mortensen M, Ehrmann DA, Littlejohn E, Rosenfi eld RL: Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab 2009; 94: 1579–1586.
45. Catteau-Jonard S, Bancquart J, Poncelet E, Lefebvre-Maunoury C, Robin G, Dewailly D: Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? Ultrasound Obstet Gynecol 2012; 40: 223–229.